R. S. Szczepaniak Sloane

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

E. Le Chatelier, N. Pons, N. Ajami, 2018, Science.

Interaction of molecular alterations with immune response in melanoma

J. Wargo, S. Reddy, V. Gopalakrishnan, 2017, Cancer.

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma

J. Wargo, A. Lazar, H. Tawbi, 2021, Oncoimmunology.